Arphra
live
S&P 5007,512.99-0.55%
NASDAQ29,968.13-1.89%
DOW51,999.67+0.64%
VIX16.41+1.30%
US10Y4.43-0.92%
EUR/USD1.1615+0.20%
GOLD4,355.5+0.47%
WTI75.90-6.78%
BTC65,667.9-0.74%
S&P 5007,512.99-0.55%
NASDAQ29,968.13-1.89%
DOW51,999.67+0.64%
VIX16.41+1.30%
US10Y4.43-0.92%
EUR/USD1.1615+0.20%
GOLD4,355.5+0.47%
WTI75.90-6.78%
BTC65,667.9-0.74%

RADL3.SA

Raia Drogasil S.A.
HealthcareMedical - PharmaceuticalsBRBRLPeers →Country macro →
$17.29
Jun 15, 2026
AI Brief
Market cap
$30.23B
52w range
P / E
EPS
Volume
Revenue · FY

Explain this page

Arphra AI
Business description
· company · SEC profile

Raia Drogasil S.A.

Raia Drogasil S.A. operates as a major retail company in Brazil, focusing on the sale of a diverse range of health and beauty products. Their offerings encompass various medicines, fragrances, personal care and cosmetic items, advanced dermocosmetics, and specialized pharmaceuticals. By March 31, 2022, the company had established a substantial network of 2,530 drugstores across 26 Brazilian states. Beyond its physical stores, Raia Drogasil also serves customers through telesales, supported by three call centers located in São Paulo, Tocantins, and Pernambuco. The firm was founded in 1905 and its corporate headquarters are in São Paulo, Brazil.

Founded
IPO
Jan 06, 2000
Employees
66,275
HQ
São Paulo, SP
CEO
Renato Cepollina Raduan
CFO
Exchange
SAO
Fiscal year
Identifiers
· company_identifiers
CIK
CUSIP
ISINBRRADLACNOR0
FIGIRADL3 BZ
LEI
Cross-listings
· companies · ISIN
  • RADL3.SAPrimarySAObrBRL$6.04B
  • RADLYOTCUSD
The global universe keeps only the primary listing; the other venues for this security are shown here.